Ginger supplementation for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
- 2023-04-11
- Meta-Analysis · n = 177
- African health sciences 23(1)
- Qun Zhou
- Ying Peng
- Fangyuan Chen
- Jianbo Dai
- PubMed: 37545930
- DOI: 10.4314/ahs.v23i1.65
- High evidence
- Clinical
ginger supplementation was associated with significantly reduced alanine aminotransferase (ALT, standard mean difference (SMD)=-0.43; 95% confidence interval [CI]=-0.85 to -0.02; P=0.04)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- not stated